CYTOKINETICS INC — Director's Dealing 2020

Jan 29, 2020

SEC Form 4/A — Form 4/A

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-01-02

Reporting Person: SMITH SANDFORD D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Non-Qualified Stock Option (right to buy)	$10.55	A	4739	Acquired	2030-01-02	Common Stock (4739)	Direct

Footnotes

F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2021.

F2: This Form 4/A is being filed to report the correct number of shares underlying the stock option, which was granted to the reporting person in connection with his election to receive 50% of his non-employee director retainer in equity, pursuant to the methodology described in the Company's most recent Proxy Statement. The number of shares reported on the Form 4 filed January 6, 2020 was incorrect due to an administrative error.